Pharmacological effects of 1,3,5-triazines and their excretion characteristics in the rat.
暂无分享,去创建一个
[1] W. J. Johnson,et al. Allantoxanamide: a potent new uricase inhibitor in vivo. , 1978, Life sciences.
[2] B. Stavric,et al. Use of the uricase-inhibited rat as an animal model in toxicology. , 1978, Clinical toxicology.
[3] G. Fanelli,et al. Uric Acid in Nonhuman Primates with Special Reference to Its Renal Transport , 1974 .
[4] Nakamura Mitsutaka,et al. Potent competitive uricase inhibitors—2,8-diazahypoxanthine and related compounds , 1973 .
[5] W. J. Johnson,et al. Uricase Inhibition in the Rat by s-Triazines , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[6] W. J. Johnson,et al. Uric Acid Nephropathy , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[7] I. Fridovich. THE COMPETITIVE INHIBITION OF URICASE BY OXONATE AND BY RELATED DERIVATIVES OF S-TRIAZINES. , 1965, The Journal of biological chemistry.
[8] J. Gut,et al. Nucleic acid components and their analogues. XX. Synthesis of oxonic acid (2,4-dioxo-1,2,3,4-tetrahydro-1,3,5-triazine-6-carboxylic acid) and the acetylation of 2,4-dioxohexahydro-1,3,5-triazines , 1962 .